In vitro production of type 1 and type 2 cytokines by peripheral blood mononuclear cells from subjects coinfected with human immunodeficiency virus and Leishmania infantum.

To explore the type 1 and type 2 cytokine profile in cases coinfected with human immunodeficiency virus (HIV) and Leishmania infantum, production of interleukin-4 (IL-4), interleukin-10 (IL-10), interferon-gamma (IFN-gamma), and interleukin-2 receptor (IL-2R) was investigated in mitogen-stimulated and unstimulated peripheral blood mononuclear cell cultures from eight HIV/Leishmania coinfected subjects matched with eight anti-HIV-positive subjects with no evidence of Leishmania coinfection. Levels of IL-4 and IL-2R increased significantly from the baseline levels in the peripheral blood mononuclear cell supernatants of HIV/Leishmania coinfected subjects following stimulation with phytohemoagglutin, whereas the postchallenge concentration of IFN-gamma was significantly increased in the HIV-infected group. The levels of IL-4 and IL-10 were significantly higher in the HIV/Leishmania group throughout evaluation. Post-stimulation IFN-gamma production was significantly higher in the HIV-positive group in comparison with that of the HIV-Leishmania coinfected subjects. These observations support the notion that a Th2 cytokine response is present during a Leishmania infection, even among HIV-coinfected individuals.

[1]  I. Weller,et al.  HIV infection alters the production of both type 1 and 2 cytokines but does not induce a polarized type 1 or 2 state , 1997, AIDS.

[2]  E. Helm,et al.  Demonstration of the Th1 to Th2 cytokine shift during the course of HIV‐1 infection using cytoplasmic cytokine detection on single cell level by flow cytometry , 1997, AIDS.

[3]  S Sharma,et al.  Circulating T helper 1 (Th1) cell- and Th2 cell-associated cytokines in Indian patients with visceral leishmaniasis. , 1997, The American journal of tropical medicine and hygiene.

[4]  P. Alzari,et al.  Interleukin 2 and its receptors: recent advances and new immunological functions. , 1996, Immunology today.

[5]  H. Doerr,et al.  Prolonged Th2 cell activation and increased viral replication in HIV-Leishmania co-infected patients despite treatment. , 1996, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[6]  G. S. Nabors,et al.  Successful chemotherapy in experimental leishmaniasis is influenced by the polarity of the T cell response before treatment. , 1996, The Journal of infectious diseases.

[7]  L. Gradoni,et al.  Visceral leishmaniasis in HIV infected patients: treatment with high dose liposomal amphotericin B (AmBisome). , 1996, The Journal of infection.

[8]  S. Raziuddin,et al.  Immunoregulatory and proinflammatory cytokine production in visceral and cutaneous leishmaniasis. , 1994, The Journal of infectious diseases.

[9]  T. Theander,et al.  Dichotomy of the human T cell response to Leishmania antigens. I. Th1‐like response to Leishmania major promastigote antigens in individuals recovered from cutaneous leishmaniasis , 1994, Clinical and experimental immunology.

[10]  G. Trinchieri,et al.  Impaired interleukin 12 production in human immunodeficiency virus- infected patients , 1994, The Journal of experimental medicine.

[11]  B. Wahrén,et al.  Increased levels of interferon‐gamma (IFN‐γ), IL‐4 and transforming growth factor‐beta (TGF‐β) mRNA expressing blood mononuclear cells in human HIV infection , 1994 .

[12]  T. Theander,et al.  Interferon‐gamma and interleukin‐4 in human Leishmania donovani infections , 1993, Immunology and cell biology.

[13]  Wynn,et al.  In vivo cytokine profiles in patients with kala-azar. Marked elevation of both interleukin-10 and interferon-gamma. , 1993, The Journal of clinical investigation.

[14]  D. Venzon,et al.  Changes in interleukin-2 and interleukin-4 production in asymptomatic, human immunodeficiency virus-seropositive individuals. , 1993, The Journal of clinical investigation.

[15]  J. Berzofsky,et al.  Role of T‐Cell Derived Cytokines in the Downregulation of Immune Responses in Parasitic and Retroviral Infection , 1992, Immunological reviews.

[16]  G. Opelz,et al.  Soluble IL‐2 receptor and tumour necrosis factor‐α in plasma of haemophilia patients infected with HIV , 1992, Clinical and experimental immunology.

[17]  G. Harms,et al.  Determinants of the immune response in visceral leishmaniasis: evidence for predominance of endogenous interleukin 4 over interferon-gamma production. , 1990, Clinical immunology and immunopathology.

[18]  H. Remold,et al.  IL-4 inhibits H2O2 production and antileishmanial capacity of human cultured monocytes mediated by IFN-gamma. , 1989, Journal of immunology.

[19]  E. Bouza,et al.  Visceral leishmaniasis in immunocompromised hosts. , 1987, The American journal of medicine.

[20]  R. Badaró,et al.  LEISHMANIA DONOVANI: AN OPPORTUNISTIC MICROBE ASSOCIATED WITH PROGRESSIVE DISEASE IN THREE IMMUNOCOMPROMISED PATIENTS , 1986, The Lancet.

[21]  S. Reed,et al.  Absence of gamma interferon and interleukin 2 production during active visceral leishmaniasis. , 1985, The Journal of clinical investigation.

[22]  Leishmania/HIV co-infection. Epidemiological analysis of 692 retrospective cases. , 1997, Releve epidemiologique hebdomadaire.

[23]  H. Doerr,et al.  Immunological findings in HIV-Leishmania coinfection. , 1996, Intervirology.

[24]  J. Alvar.  Leishmaniasis and AIDS co-infection: the Spanish example. , 1994, Parasitology today.

[25]  M. Clerici,et al.  A TH1-->TH2 switch is a critical step in the etiology of HIV infection. , 1993, Immunology today.

[26]  S. Reed,et al.  Cytokine activation of human macrophages infected with HIV-1 to inhibit intracellular protozoa. , 1992, Journal of acquired immune deficiency syndromes.